KLOXXADO is a prescription 8 mg naloxone nasal spray designed for the emergency treatment of opioid overdose. The agreement expands Emergent's portfolio of life-saving opioid overdose treatments ...
Systemic Bio was recognized for its cutting-edge platform, which leverages advanced bioprinting technologies to create complex vascularized tissue models. “We are thrilled to be recognized by SLAS as ...
Hikma Pharma Inks Exclusive Commercial Deal With Emergent BioSolutions For KLOXXADO Nasal Spray 8 Mg
(RTTNews) - Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent BioSolutions for the sale of KLOXXADO naloxone HCl nasal ...
Systemic Bio was recognized for its cutting-edge platform, which leverages advanced bioprinting technologies to create complex vascularized tissue models. “We are thrilled to be recognized by ...
Vistagen , a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced positive results from an exploratory Phase 2A study of PH284 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback